Morgan Hakki

Morgan Hakki, MD is a Professor in the Department of Medicine at the University of Washington School of Medicine, specializing in infectious diseases with a focus on transplant recipients and immunocompromised hosts. His research spans virology, bacteriology, and clinical management of infections in high-risk patients, particularly those undergoing hematopoietic cell transplantation.

Dr. Hakki received his medical degree from Temple University School of Medicine in 1997, completed his internal medicine residency at University of Michigan Hospitals (1997-2000), and pursued fellowship training in infectious diseases at University of Washington/Fred Hutchinson Cancer Research Center (2000-2003).

His primary research interests center on infections in immunocompromised hosts, with particular expertise in cytomegalovirus and Pseudomonas aeruginosa infections. Over his career, Dr. Hakki's work has evolved from basic virology research on viral mechanisms to more clinical and translational studies addressing infection prevention and management in transplant settings. His most recent work focuses on antimicrobial resistance patterns, novel treatment approaches for multidrug-resistant pathogens, and optimizing prophylaxis strategies for transplant recipients.

Analysis of his publication trends reveals a consistent focus on transplant infectious diseases, with increasing emphasis on antimicrobial resistance mechanisms and clinical management strategies in recent years. His work frequently addresses practical clinical challenges in managing infections among hematopoietic cell transplant recipients and patients with hematologic malignancies.

Dr. Hakki has been actively involved in multicenter clinical research collaborations, particularly with the American Society for Transplantation and Cellular Therapy, contributing to evidence-based guidelines for infection prevention and management in transplant settings. His work has informed clinical practice through numerous publications in high-impact journals across infectious diseases, transplantation, and antimicrobial therapy.

His laboratory and clinical research have primarily focused on understanding pathogen-host interactions in immunocompromised settings, with recent work examining environmental reservoirs of resistant pathogens and developing strategies to prevent transmission in healthcare settings. Dr. Hakki maintains active collaborations with transplant teams across multiple institutions to address emerging infectious threats in vulnerable patient populations.